Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Operating Expenses | 7,045 | 4,425 | 4,138 | 1,484 | 1,609 |
| Operating Income | -7,045 | -4,425 | -4,138 | -1,484 | -1,609 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | 968 | 7,940 | -12,561 | -4,396 | 189 |
| Pre-tax Income | -6,077 | 3,515 | -16,700 | -5,880 | -1,421 |
| Net Income Continuous | -6,077 | 3,515 | -16,700 | -5,880 | -1,421 |
| Net Income | $-6,077 | $3,515 | $-16,700 | $-5,880 | $-1,421 |
| EPS Basic Total Ops | -6.31 | 4.20 | -19.82 | -7.51 | -1.80 |
| EPS Basic Continuous Ops | -6.40 | 4.09 | -19.88 | -7.67 | -1.81 |
| EPS Diluted Total Ops | -6.31 | 3.00 | -19.82 | -7.51 | -1.80 |
| EPS Diluted Continuous Ops | -6.40 | 2.94 | -19.88 | -7.67 | -1.81 |
| EBITDA(a) | $-7,031 | $-4,417 | $-4,137 | $-1,484 | $-1,609 |